dutasteride sumar pharma (dutasteride ratiopharm) mjúkt hylki 0,5 mg
alvogen ehf. - dutasteridum inn - mjúkt hylki - 0,5 mg
fentanyl actavis forðaplástur 100 míkróg/klst.
actavis group ptc ehf. - fentanylum inn - forðaplástur - 100 míkróg/klst.
fentanyl actavis forðaplástur 25 míkróg/klst.
actavis group ptc ehf. - fentanylum inn - forðaplástur - 25 míkróg/klst.
fentanyl actavis forðaplástur 50 míkróg/klst.
actavis group ptc ehf. - fentanylum inn - forðaplástur - 50 míkróg/klst.
fentanyl actavis forðaplástur 75 míkróg/klst.
actavis group ptc ehf. - fentanylum inn - forðaplástur - 75 míkróg/klst.
fentanyl alvogen (fentanyl ratopharm) forðaplástur 12 míkróg/klst.
alvogen ehf. - fentanylum inn - forðaplástur - 12 míkróg/klst.
fentanyl alvogen (fentanyl ratiopharm) forðaplástur 50 míkróg/klst.
alvogen ehf. - fentanylum inn - forðaplástur - 50 míkróg/klst.
zassida stungulyfsstofn, dreifa 25 mg/ml
zentiva k.s.* - azacitidinum inn - stungulyfsstofn, dreifa - 25 mg/ml
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - Öll önnur lækningavörur - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - taugakerfi - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.